Home
At a glance
Contact us
Home
»
Media
Publications
01 December 2009
Triptorelin 6-Month Formulation in the Management of Patients with Locally Advanced and Metastatic Prostate Cancer
11 June 2009
The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muslce apoptosis and ultrastructural defects in Col6a1-/- mypathic mice
08 May 2009
The Cyclophilin Inhibitor Debio 025 Combined with PEG IFNα2a Significantly Reduces Viral Load in Teatment-Naïve Hepatitis C Patients
23 February 2009
Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist
02 February 2009
An evaluation of the cyclophilin inhibitor Debio 025 and its potential as a treatment for chronic hepatitis C
« Newer
Older »
1
/18
Debio 025
( 37 Articles )
Triptorelin / Decapeptyl / Trelstar
( 7 Articles )
Oxaliplatin - Eloxatin - Elplat
( 12 Articles )
Debio 0614
( 3 Articles )
Debio 0719
( 6 Articles )
Debio 9902 - ZT-1
( 8 Articles )
Debio 8609 Sanvar
( 1 Article )
Archives
( 15 Articles )
Latest News
09 November 2011
Augurix Diagnostics receives the 2011 ‘Debiopharm /Valais Award’ For its point-of-care diagnostic test for the early detection of Celiac disease
05 October 2011
The Japanese Cancer Association and Debiopharm Group™ present Doctors Arakawa and Kurokawa with the 2011 ‘JCA-Mauvernay Award’for their innovative and outstanding research in the field of cancer
08 September 2011
Debiopharm Group™ presents the ‘Debiopharm Group™ Life Sciences Award 2011’ and two ‘Junior Debiopharm Group™ Awards 2011’ at the ISREC 2011 Life Sciences Symposium
About us
Our business
Responsibility
Careers
Media
Press Releases
Publications
Archives
Download center
Events
Debiopharm on
Legal Notice
Credits
Sitemap
© 2012 Debiopharm Group
